论文信息 - Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study - 字舞流文

Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study

A. Tzouvelekis | K. Akinosoglou | D. Velissaris | T. Karampitsakos | V. Georgiopoulou | M. Marangos | V. Dimakopoulou | I. Oikonomou | F. Sampsonas | O. Papaioannou | E. Zarkadi | E. Malakounidou | M. Katsaras | C. Davoulos | P. Tsiri | G. Tsirikos | K. Akinosoglou